NOG and fragile X syndrome: We previously used a 45-day approach involving dual-SMAD inhibition only (Noggin/TGFß inhibition) to differentiate FXS hESCs to neurons, which was used to show that the differentiation of FXS hESCs leads to FMR1 silencing and the loss of detectable FMRP protein [6].